tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Percher, 6 are a HOLD (42.86%), 1 are a SELL (7.14%), 7 are a BUY (50%).
Analyst Eric Percher, currently employed at NEPHRON RESEARCH, carries an average stock price target met ratio of 66.67% that have a potential upside of 17.7% achieved within 801 days. Previously, Eric Percher worked at BARCLAYS.
Eric Percher’s has documented 34 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MCK, McKesson at 19-May-2017.
Analyst best performing recommendations are on CERN (CERNER CORP).
The best stock recommendation documented was for CERN (CERNER CORP) at 1/19/2017. The price target of $52 was fulfilled within 13 days with a profit of $2.04 (4.08%) receiving and performance score of 3.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Nov-2018
$180
$-155.65 (-46.37%)
Hold Since 12-Nov-2018
$150
$-185.65 (-55.31%)
Hold Since 12-Nov-2018
$160
$-175.65 (-52.33%)
$160
Hold Since 12-Nov-2018
$179
$-156.65 (-46.67%)
$173
Buy Since 12-Nov-2018
$142
$-193.65 (-57.69%)
What Year was the first public recommendation made by Eric Percher?
